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Abstract The efficient transport of blood and lymph
relies on competent intraluminal valves that ensure unidi-
rectional fluid flow through the vessels. In the lymphatic
vessels, lack of luminal valves causes reflux of lymph and
can lead to lymphedema, while dysfunction of venous
valves is associated with venous hypertension, varicose
veins, and thrombosis that can lead to edema and ulcer-
ations. Despite their clinical importance, the mechanisms
that regulate valve formation are poorly understood and
have only recently begun to be characterized. Here, we
discuss new findings regarding the development of venous
and lymphatic valves that indicate the involvement of
common molecular mechanisms in regulating valve for-
mation in different vascular beds.
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Control of fluid flow through the vascular system:
importance of valves
The circulatory system is composed of the heart and the
blood vessels, which distribute nutrients, hormones, gases,
and metabolic waste products in the body, and the lym-
phatic vessels that ensure that the extravasated fluid and
proteins are drained from the tissues and transported back
to the blood circulation. The beating of the heart generates
pulsatile flow of blood that is pushed through a hierarchical
network of arteries, capillaries, and veins, with heart valves
controlling the flow of blood through the heart by opening
and closing during the contractions of the heart. In addi-
tion, contraction of skeletal muscles compresses the walls
of deep veins and drives the movement of blood inside the
vessels, thus behaving like peripheral muscle pumps [1].
Additional mechanisms that activate the venous pumping
system include arterial pulsation and the ankle joint pump,
which is generated by ankle joint motion [2], while luminal
valves in the veins ensure unidirectional blood flow
(reviewed in [3]). Venous valves are required for efficient
return of blood particularly from lower extremities, where
the greatest gravitational forces are present.
Like the blood vasculature, the lymphatic system is
composed of a hierarchy of vessels with specific features
serving their unique functions: the blind-ended lymphatic
capillaries (also called initial lymphatics) that absorb the
interstitial fluid and the collecting lymphatic vessels that
transport the lymph to the cardiovascular system (reviewed
in [4]). In birds and amphibians, specialized lymph hearts
are responsible for lymph propulsion while extrinsic
mechanisms such as skeletal muscle contractions play a
negligible role [5]. Mammals do not have lymph hearts and
both intrinsic and extrinsic forces are important for effi-
cient lymph propulsion. Extrinsic pump mechanisms
include cardiac and arterial pulsations, skeletal muscle
contractility, venous pressure fluctuations, peristaltic
movement of the intestine, and respiration. The extrinsic
mechanisms play an important role in controlling the
opening of the specialized cell–cell junctions, so-called
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primary valves, in lymphatic capillaries [6, 7]. Collecting
vessels are affected by the same extrinsic factors; however,
their function is mainly controlled by intrinsic mechanisms
that depend on the contraction of the smooth muscle cells
around the vessels and the action of intraluminal valves
that prevent backflow of the lymph [8, 9]. An important
regulatory mechanism of lymphatic pumping is triggered
by high nitric oxide (NO) concentration in the valve area,
which is due to increased expression of eNOS in valve
endothelia [10].
Consistent with their important functions, incompetence
of venous valves has clinical implications and is associated
with venous hypertension, orthostatic leg swelling, devel-
opment of varicose veins, and leg ulcerations [3, 11, 12].
Dysfunction of lymphatic valves can similarly contribute to
clinical disease. For example, lack of valves underlies
lymphatic failure and consequent edema in patients with a
form of primary hereditary lymphedema called Lymphe-
dema Distichiasis [13, 14].
Fluid dynamics of the valve
Recent advances in ultrasound technology have given
insight into the physics of venous valve operation and have
delineated the way the movement of the leaflets affects
blood flow into four distinct phases of the valve cycle:
opening, equilibrium, closing, and closed (Fig. 1) [15]. An
increase in pressure behind the closed leaflets forces them
to push back towards the vessel wall and create an opening
while the stagnated blood between the leaflets and the sinus
wall is pushed forward. Once open, the leaflets remain
suspended in the flowing bloodstream and undergo self-
excited oscillations [15], while the blood flow through the
valve orifice separates at the oscillating edges of the valve
leaflets to create one axial flow jet in the middle of the
opening and two recirculation vortices of lower speed in
the sinus, causing distention of the valve sinus [15, 16].
While the pressure in the recirculation vortex is in equi-
librium with the pressure exerted on the inflow side of the
leaflets, the valve remains open. Changes in any of these
streams can shift this balance so that, with rising pressure
on the outflow side and decreasing pressure on the luminal
side, the valve leaflets simultaneously move towards the
center of the vessel and then remain closed until a new
cycle starts [15]. These hemodynamic events are prede-
termined by the solid mechanics of the valve leaflets and
the perivalvular area, and constitute a self-sustained
mechanism for competent valve operation [15, 17]. A
similar flow separation model has been validated [16, 18,
19] at the orifice of the aortic valves of the heart, first
proposed by Leonardo da Vinci [20], and was recently
suggested to apply to lymphatic valves, as similar opening
and closing motions of the lymphatic valve leaflets have
recently been recorded in excised vessels and in vivo
[21, 22].
Valve morphogenesis
The mature venous and lymphatic valves are typically
bicuspid, and are composed of two luminal leaflets that
consist of two layers of endothelial cells separated by a
defined connective tissue core ([23–26]; Fig. 2a, b). Uni-
cuspid venous valves, as well as bicuspid, and at least in
veins, tricuspid valves composed of leaflets of unequal size
have also been observed [23, 27]. The development of
venous [28] and lymphatic [29] valves was first charac-
terized by Kampmeier in the late 1920s (Fig. 3a):
‘‘The bicuspid valve begins as a pair of inconspicuous
and more or less transversely placed endothelial
Fig. 1 Fluid dynamics of a valve. Distinct phases of opening and
closing of valve leaflets (blue): opening, equilibrium, closed, and
closing, modified from [12]. Fluid pressure drop across the vessel
drives direction of flow (black hollow arrow), while forces on either
side of valve leaflets (blue, Popen, Pclose) determine the leaflets’
position inside the lumen and the size of the valve orifice. Black
arrows point at the distinct flow patterns as well as the fluid velocities
at different parts of the valve pocket (relatively scaled to demonstrate
magnitude differences), such as axial flow in the middle of the vessel
and detached streamlines at the free ends of the open leaflets
developing into vortices in the sinus. Gray line shows the level of the
vessel distension during the opening phase of the valve
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ridges inside the vein. By the invasion of the mes-
enchyme, the elongation and slanting of the ridges,
and the formation of a concavity on their leeward
face, the anlagen are gradually converted into vulvar
sacs. Coincident with such changes, the venous cavity
flares outward at the level of these sacs, so aiding in
the production of their sinus [28].’’
Recent studies using high-resolution imaging techniques
have confirmed Kampmeier’s accurate description of the
basic morphogenic events during valve formation. In
addition, analyses of genetic mouse models have provided
important insight into the molecular and cellular mecha-
nisms regulating morphogenesis of both lymphatic and
venous valves. Below, we describe the sequence of
developmental events and the molecular mechanisms
operating during early onset of valve development, leaflet
elongation, and valve maintenance in lymphatic vessels
and veins.
Onset of valve development: defining the positions
While it is not fully understood how the process of valve
development is initiated, it was recently shown that
mechanical forces caused by fluid flow regulate the
expression of key molecular regulators and cellular
behaviours associated with valve-forming lymphatic
endothelial cells [22]. Mechanical stimulus from fluid flow
may therefore establish the locations where lymphatic
valves develop. Indeed, valve position is not stochastically
determined: although venous valves may follow each other
in immediate succession, more frequently they are
observed at stereotypic positions distal to the entrance of
tributaries [27]. Similarly, lymphatic valves are often found
in vessel bifurcations and branch points [22, 24], i.e. in
geometries that are characterized by distinct flow and shear
stress patterns [30]. Lymphatic endothelial cells that were
exposed to oscillatory fluid shear stress, which was used to
model the disturbed flow present in vessel branches [30],
were shown to recapitulate multiple aspects of endothelial
cell responses observed during early stages of valve for-
mation, including upregulation of Foxc2 and activation of
NFAT/Calcineurin signaling, as well as cytoskeletal rear-
rangement and changes of cell shape and alignment [22].
Notably, however, the timing of the onset of valve devel-
opment appears to be different in veins and lymphatic
vessels (Fig. 2c). In the mesenteric lymphatic vessels in
mouse, the initiation of valve formation is correlated with
the onset of lymph flow [22] and occurs concomitantly
with remodeling of a primary lymphatic vascular plexus,
characterized by a branched network of capillary-type
vessels, into functional collecting vessels, while no de novo
formation of luminal valves has been reported in
established mature vessels ([24, 31], Fig. 2c). In contrast,
the development of valves in the femoral vein in mouse
was shown to occur during early postnatal development
[32], indicating that the process starts after flow has already
been present in the vessels and the gross morphology of the
vein is no longer changing. However, in human fetuses,
venous valves were already observed during early devel-
opment (at 13 weeks of pregnancy) [33], and, as in the
lymphatic system, it appears that venous valve initiation in
some vascular beds occurs concomitantly with the
remodeling of a venous plexus into hierarchy of deep,
superficial and communicating veins [34]. Apart from
experiencing different shear forces generated by the fric-
tion of the flowing blood or lymph on the surface of the
vessels, the tangential wall tension caused by fluid pressure
in the veins and lymphatic vessels is likely to be different.
Venous valve development starts after the vessels have
acquired a uniform smooth muscle cell coverage, which
controls lumen shape and size and prevents overdistension.
In contrast, the initial stages of lymphatic valve develop-
ment precede smooth muscle cell recruitment to the vessels
([24, 31], Fig. 2c). These observations suggest that endo-
thelial cells that are found at valve initiation sites in veins
and lymphatic vessels experience very different levels of
shear stress and tangential wall tension, yet they undergo
similar molecular and morphological changes (see below),
suggesting that factors other than flow are additionally
involved in the initiation of valve development.
Interestingly, the early stages of heart valve formation
share some common features with lymphatic and venous
valve development. In mice, heart valve formation occurs
as a result of endocardial cushion formation when signals
derived from myocardium induce an endothelial-to-
mesenchymal transition of adjacent endothelial cells
(reviewed in [35, 36]). These endothelial-derived progen-
itors contribute to valvuloseptal structures and valve
interstitial cells that play an important role in the remod-
eling of the valve extracellular matrix and formation of the
leaflets [35, 36]. In zebrafish, however, heart valves appear
to emerge at the atrioventricular boundary directly through
an invagination of the endothelium, rather than from
mesenchymal cushion [37], similarly as described for
venous and lymphatic valves. In addition, like lymphatic
valve morphogenesis [22], the early stages of zebrafish
heart valve development are characterized by transition of
the valve-forming cells to cuboidal shape [38]. Impor-
tantly, intracardiac hemodynamics were also shown to play
a critical role in heart valve development: oscillatory blood
flow between the atrium and ventricle was found to lead to
upregulation of the shear-responsive gene Klf2a, an
essential hemodynamic regulator gene ([39], Klf2 in mice),
and important regulator of normal valvulogenesis [40].
Interestingly, this study suggested that the effects of blood
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flow operate only after an initial patterning that is guided
by a genetic program, since the early stages of valve
development, characterized by clustering of endothelial
cells at the atrioventricular boundary and formation of an
endothelial ring, did not require flow, and nor did they
depend on Klf2a function [40]. Finally, some of the
molecular mechanisms regulating the formation of valves
in different parts of the vascular system are shared, such as
the requirement of Calcineurin signaling for heart and
lymphatic valve development ([22, 31, 41, 42], see below).
Establishment of the valve territory
The first indication of lymphatic valve development is the
appearance and clustering of cells expressing elevated
levels of two transcription factors, Prox1 and Foxc2, in
defined positions along the vessel ([22, 24, 31, 32];
Figs. 2c, 3b). This population of valve-forming endothelial
cells subsequently rearranges and reorients perpendicular
to the longitudinal axis of the vessel to form a ring-like
constriction ([24, 32]; Fig. 3b). Cell rearrangement coin-
cides with the deposition of extracellular matrix containing
Fibronectin-EIIIA/EDA (FN-EIIIA) splice isoform and
Laminin-a5, and upregulation of the cell–matrix adhesion
receptor Integrin-a9 in valve-forming endothelial cells
([24]; Fig. 3b). Compared with other endothelial cells on
the vessel wall, the valve-forming cells also express higher
levels of certain junctional molecules such as CD31/PE-
CAM-1, VE-Cadherin, and specific Connexins, while the
expression of transmembrane proteins LYVE-1 and NRP2
is downregulated [22, 43]. The valve-forming cells can
therefore be defined as a molecularly distinct population of
lymphatic endothelial cells. Similarly, in the veins, one
of the first signs of valve development is the induction of
Prox1 expression, which is followed by upregulation of
Integrin-a9 [32]. In addition, the transmembrane EphB
ligand Ephrin-B2 is upregulated in the valve-forming
venous endothelial cells during early stages of valve
development. Prox1 was also found in endothelial cells
of lympho-venous and cardiac valves [44, 45]. Intriguingly,
previous studies have established Prox1 as a master regu-
lator of lymphatic endothelial cell fate [46], while Ephrin-
B2 is a well-established marker of arterial and lymphatic
endothelia [47, 48]. The unexpected expression of these
genes in developing venous valves suggests that the valve
endothelial cells possess a unique identity. Interestingly,
the venous endothelial cells, considered to represent
terminally differentiated cell types, are thus capable of
switching their identity upon initiation of valve formation.
Upon their induction, Prox1 and Foxc2 control, in
response to flow, the expression and activation of the two
important downstream regulators of valve formation,
Connexin-37 and NFATc1 [22, 31, 43], suggesting their
key role in further defining the identity of valve-forming
cells. In agreement, Foxc2 deficiency in mice and humans
leads to lymphatic valvular aplasia [14, 31]. Conse-
quently, human patients with FOXC2 mutations develop
lymphedema [49]. Reflux in great saphenous veins in
these patients suggests an important function for FOXC2
also in the formation of venous valves [13]. While the
function of Prox1 in venous or lymphatic valves has not
been investigated, Prox1 deficiency in mice leads to
defective lympho-venous valve formation [45], implying
that Prox1 is similarly involved in controlling valve
development in different vessel types. Interestingly,
Gata2, another transcription factor that shows a prominent
expression in lymphatic valves, was found to regulate the
expression of Prox1, Integrin-a9, and Ephrin-B2, sug-
gesting that it may also play an important role in early
stages of valve development [50]. Inactivating mutations
in GATA2 were identified as responsible for Emberger
syndrome, an autosomal dominant primary lymphedema
that is associated with a predisposition to acute myeloid
leukemia (AML) [51], as well as in familial myelodys-
plastic syndrome/AML or MonoMAC syndrome and
primary lymphedema [50]. However, it is not known
whether valve defects underlie the lymphatic failure in
these patients.
Connexin-37 (Cx37) is highly expressed in lymphatic
valve-forming cells and regulates their rearrangement to
a ring-like constriction during early stages of valve
Fig. 2 Similarities and differences between valve formation process
in veins and lymphatic vessels. a First drawing of a valve, by
Salomon Alberti in 1585 ([28], reproduced from [27], Copyright
(1927), Royal Society Medicine Press, UK), showing the outside and
inside of part of a leg vein (indicated by A, B) with a tributary vein
(C). D and E indicate the two cusps of a bicuspid valve. b Transmis-
sion electron microscopy of the tip of a lymphatic valve leaflet
L lumen, S sinus. Matrix core of the leaflet is highlighted in pink and
flow direction is indicated by an arrow. Scale bar 2 lm. c Schematic
of the developmental process of valve formation in veins (top row,
blue) and lymphatic vessels (bottom row, green). Direction of blood/
lymph flow and color codes representing different tissues are shown
below. Developmental time-points, as determined for the valves in the
proximal femoral vein and mesenteric lymphatic vessels in mice, are
indicated below each stage; E embryonic, P postnatal. Note the
presence of uniform smooth muscle coating (brown) in veins prior to
valve initiation, while sparse coverage of SMCs is acquired to
lymphatic vessels only after valve formation and concomitant
remodeling of a primitive vascular plexus to mature collecting
vessels. Valve initiation in both veins and lymphatic vessels is
characterized by emergence of clusters of cells expressing high levels
of Prox1 and Foxc2 transcription factors (dark green nuclei),
predominantly near vessel branch points, and followed by formation
of leaflets with two layers of endothelial cells expressing Integrin-a9
(light green) attached to Laminin-a5 positive matrix core (red).
Bottom confocal micrograph of a dermal collecting lymphatic vessel
stained for Laminin-a5 to visualize the extracellular matrix core of
the valve leaflet (green) and aSMA to highlight smooth muscle cells
around the vessel (red). Scale bar 50 lm
1058 E. Bazigou, T. Makinen
123
development, suggesting the importance of gap-junctional
communication during this process ([22, 43]; Fig. 3b). Two
other Connexins, Cx43 and Cx47, were shown to be enri-
ched in mature lymphatic valves [22, 43]. Interestingly,
Cx43 deficiency in mice also led to abnormal lymphatic
development, including defective valve formation [43],
while GJC2 (encoding Cx47) was found to be mutated in
lymphedema patients [52, 53]. These studies suggest a
more general role for gap-junction-mediated signaling in
the lymphatic vasculature. Calcineurin signaling, which
regulates nuclear translocation of NFAT transcription fac-
tors, is also activated during early stages of lymphatic
valve development and is required for the formation of a
defined boundary of valve-forming cells [22, 31].
Lymphatic and venous valve morphogenesis 1059
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Development of valve leaflets and sinus formation
The development of valve leaflets is initiated by the for-
mation of a transverse ridge on the vessel wall, which is
followed by the elongation of the leaflets into the vessel
lumen and formation of the commissures ([32]; Fig. 3a, b).
In both lymphatic vessels and veins, this process critically
depends on the assembly of an extracellular matrix core
within developing leaflets through interaction of a cell–
matrix adhesion receptor integrin-a9 with one of its
ligands, Fibronectin, containing the alternatively spliced
EIIIA/EDA domain [24, 32]. Interestingly, FN-EIIIA is
deposited specifically at the sites of developing lymphatic
valves and is subsequently localized at the free ends of the
extending leaflets, suggesting requirement for an integrin-
specific mechanism of fibronectin fibrillogenesis in the
formation of the valve matrix core [24].
Other signaling pathways important for both lymphatic
and venous valve formation include Ephrin-B2, a trans-
membrane ligand for EphB receptor tyrosine kinases
[32, 48]. In particular, ‘reverse signaling’, mediated via
binding of PDZ domain containing effector molecules to
the cytoplasmic domain of Ephrin-B2, was shown to be
critical for normal lymphatic valve formation [48]. How-
ever, the precise morphogenetic process affected by loss of
Ephrin-B2 and the critical receptor(s) mediating this effect
have not been characterized. Interestingly, apart from its
interaction with EphB receptors, Ephrin-B2 regulates the
internalization and signaling of the major lymphangiogenic
receptor tyrosine kinase, VEGFR-3 [54], which is strongly
Fig. 3 Model of valve morphogenesis. a Schematic representation of
the development of a bicuspid venous valve by Kampmeier in 1927
([28], reproduced from [27], Copyright (1927), Royal Society
Medicine Press, UK). Endothelial layer is shown in white and
mesenchymal layer in black. Flow direction is indicated by arrows;
t tributary. b Schematic model of lymphatic valve morphogenesis.
Some of the key regulators of different stages of valve formation are
shown. Green text indicates expression in lymphatic endothelial cells,
dark brown smooth muscle cells, and red extracellular matrix
components. The initiation of valve formation coincides with the
initiation of lymph flow in mesenteric lymphatic vessels. Clusters of
endothelial cells expressing high levels of Prox1 and Foxc2
transcription factors (dark green nuclei) emerge at the sites of
developing valves, which is followed by deposition of matrix
molecules, such as Laminin-a5 (red) and establishment of valve
territory via Calcineurin and Connexin signaling. Valve leaflet
formation is initiated by the formation of an endothelial cell ring-
like constriction and depends on Integrin-a9-mediated assembly of
FN-EIIIA matrix. Repulsive signaling between Sema3A and NRP1
maintains valve areas free of smooth muscle cells (SMC, brown),
while Calcineurin and Ephrin-B2 signaling regulate the maintenance
of valve leaflets
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expressed in the developing and mature lymphatic valves
[31], and transiently in the developing venous valves [32].
The function of VEGFR-3 in valve formation has not been
directly studied; however, VEGFR-3 signaling was found
to co-operate with Foxc2 in the development of lymphatic
valves [14]. In addition, Milroy patients who present with a
congenital form of lymphedema caused by inactivating
VEGFR3 mutations have reflux in their great saphenous
veins [55], pointing to a potential role for VEGFR-3 in
valve development.
High expression of another endothelial receptor tyrosine
kinase, Tie2, was reported in venous valves, starting from
the earliest developmental stages [32]. Interestingly,
Angiopoietin2, the ligand for Tie2, is required for the
maturation of the lymphatic vessels and the formation of
lymphatic valves [56]. Experiments using cultured endo-
thelial monolayers in vitro revealed that Tie2 is
upregulated and activated upon exposure of cells to shear
stress [57, 58], suggesting that Tie2 mediated signaling
may be involved in regulating flow-mediated responses,
and thus early stages of valve formation. Similarly, shear
stress induces the activation of the phosphoinositide
3-kinase (PI3K)/Akt pathway [59], which is activated
under exposure to flow downstream of Tie2 signaling [57,
58]. While the function of Tie2 in valve formation has not
been studied, it is interesting to note that mice lacking the
regulatory isoforms of the class Ia PI3K, p85a/p55a/p50a,
show severe defects in the intestinal lymphatic vessels,
including lack of valves [60]. In addition, lack of Akt1
leads to more specific defects in the formation of lymphatic
valves in the superficial collecting vessels of the skin [61].
Concomitant with the formation of the valve leaflets, the
vessel wall opposite the leaflets dilates to create a pocket
on the side of each leaflet called the valve sinus. It has been
demonstrated that the endothelial cells in the venous valve
sinus behave differently from the ones in avalvular areas
and have the ability to stretch twice as much [62]. Similar
measurements have not been made in lymphatic valve
sinuses; however, it is known that they are devoid of
smooth muscle cells [14], which is likely to enable more
extensive stretching of the vessel wall in this region. The
importance of the lack of smooth muscle cells in lymphatic
valves for their normal development and function was
recently demonstrated. Sema3A, produced by lymphatic
endothelial cells, was shown to repel smooth muscle cells
expressing its receptor, NRP-1, thereby maintaining valve
areas smooth muscle free [63, 64]. Sema3A was addi-
tionally shown to regulate valve leaflet formation via
interaction with NRP-1 and PlexinA1 on valve endothelial
cells [63]. Other molecular regulators that may play a role
in valve sinus formation or function in veins include anti-
coagulant markers endothelial protein receptor (EPCR) and
thrombomodulin that are strongly expressed on venous
valve leaflet and sinus, while procoagulant factors, such as
VWF, present the opposite pattern [65, 66]. Such distri-
bution of anti- and procoagulant factors in the valve pocket
favors anticoagulation, and thus is protective from
thrombosis.
Establishment of the unique cellular identity of valve
endothelium
The shared molecular identity and genetic regulation of
valves in veins and lymphatic vessels, characterized by
expression of several genes previously thought to be
restricted to lymphatic and/or arterial endothelium such as
Foxc2, Prox1, Integrin-a9 and Ephrin-B2 (Fig. 4a, b), rai-
ses the interesting question of how the unique valve
endothelial cell identity is established. As discussed above,
the initiation of lymph flow and the resulting shear forces
were suggested to define the positioning, but also the
identity, of valve-forming cells [22]. This study reported
upregulation of Foxc2 in vitro in lymphatic endothelial
cells that were subjected to oscillatory flow, while Prox1
levels were not affected. In contrast, in another study, flow-
induced downregulation of Prox1 was observed both in
cultured cells in vitro and in adult lymphatic vessels in vivo
[67]. In addition, Prox1 was upregulated in embryonic
mesenteric lymphatic vessels that were cultured ex vivo in
the absence of fluid flow [22], which could be regarded as
evidence for flow-induced downregulation of Prox1
expression that normally occurs in lymphangions (lym-
phatic vessel segments inbetween two consecutive valves).
It should be noted that the first study examined flow-reg-
ulated responses under oscillatory shear stress, which was
used to mimic disturbed flow patterns in the immature
lymphatic vascular plexus, while the latter study used
steady laminar flow. In addition, the shear stress levels that
were applied were different. Since no measurements of
shear or tangential wall stresses that are present in the
developing lymphatic vessels are available, future work
should investigate in more detail the precise mechanisms of
valve initiation by lymph flow.
While the onset of blood flow cannot provide a complete
explanation for the timing of the initiation of venous valve
formation that occurs postnatally, the observed molecular
and morphological differences between endothelial cells in
different parts of the valve suggest the involvement of
flow-induced forces in modulating cellular phenotypes
during later stages of valve formation. For example, cells
that are located upstream of the valve are elongated and
aligned in the direction of flow, while the cells on either
surface of the leaflets or lining the juxtaposed vein wall
(valve sinus) appear to have a rounded or cuboidal mor-
phology ([32]; Fig. 4c, f). Another study reported
differences in the shape of cells located within different
Lymphatic and venous valve morphogenesis 1061
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regions of the leaflet; endothelial cells on the medial sur-
face of the valve leaflet were found to orient parallel to the
long axis of the vessel, whereas those on the lateral surface
aligned perpendicular to that axis [68]. Interestingly, the
free ends of the valve leaflets are lined by endothelial cells
that have a transverse arrangement and fusiform mor-
phology (Fig. 4f). Lymphatic valve endothelial cells
acquire a similar morphology in the respective areas of the
valve; for example, appearing fusiform on the free edges
[69] and elongated upstream of the valve [22, 24]. The
elongated morphology of endothelial cells in venous and
lymphatic vessel segments devoid of valves corroborates
the observed steady attached flow conditions the cells
experience, while the cuboidal shape of cells lining the
leaflets suggests unsteady or oscillating shear. According to
Poiseuille’s equation that describes parabolic velocity
profile for laminar flow inside the tube, valve endothelial
cells located in the most stenotic regions of the vessels, i.e.
on the leaflet, experience higher wall shear stress than the
cells lining the vessel wall; however, it is unlikely that this
is a steady condition. Instead, valve endothelial cells are
likely to experience unsteady flow patterns due to the
oscillatory movement of the leaflets during equilibrium
phase as well as small volume regurgitation [70], which is
reflected in their cuboidal morphology. At the molecular
level, differential expression of Prox1 and Ephrin-B2 was
observed in vivo in cells that are exposed to different flow
conditions within the valve. While Prox1 was predomi-
nantly expressed in the fusiform cells on the free edges of
the valve leaflets (Fig. 4b), Ephrin-B2 was present on the
Fig. 4 The molecular identity and morphology of valve endothelial
cells. a, b Confocal micrographs of a mesenteric lymphatic vessel
(a) and a femoral vein (b) stained for Integrin-a9 and Prox1 to
visualize valve endothelial cells (red) and their nuclei (green),
respectively. Image (b) reproduced from [32]), Copyright (2011), The
Journal of Clinical Investigation, USA). Asterisks in (b) indicate a
Prox1? lymphatic vessel running in parallel of the vein. c–f Scanning
electron microscope micrographs of a venous valve, showing
different endothelial cell phenotypes (regarding cell shape and
alignment) in different parts of the valve. Cells on the leaflet show
rounded morphology (d) while cells on the inflow side (upstream) of
the valve show elongated morphology and align in flow direction (e).
The free edges of the leaflets are composed of cells that show
transverse orientation and are highly elongated (f, arrows). I inflow,
O outflow, L leaflet. Scale bars (a, b) 50 lm, (c, f) 10 lm, (d, e) 5 lm
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leaflet and on the sinus wall on the outflow side of venous
valve [32]. Intriguingly, the Prox1? fusiform cells are
highly elongated [32], which is in contrast to the role of
Prox1 in regulating transition to a cuboidal cell shape
during early stages of lymphatic valve development [22].
In summary, these observations suggest that the morpho-
logical and molecular characteristics that valve endothelial
cells acquire reflect the distinct forces they experience.
Consistent with this, differences in flow patterns and shear
stress magnitude were previously shown to regulate gene
expression and arterial-venous [71, 72] as well as lym-
phatic differentiation [67]. However, in addition to
different forces, the cells experience different extracellular
environments, with specific matrix components, such as
Laminin-a5, present in the valve leaflet compared to the
vessel wall, and lack of smooth muscle cell contact in valve
endothelia. These factors are also likely to play an
important role in defining the cellular identity of valve
endothelial cells.
Valve maintenance in adults and during aging
The mature venous valve leaflets are thicker at the sites of
attachment to the vessel wall containing condensely packed
collagen fibers; however, this deteriorates with age, thus
making the valve leaflets more fragile [73]. It has also been
recognized that stagnation of blood flow at the junction of
valve leaflet and vessel wall can initiate microthrombus
formation (reviewed in [17]). Although venous valves are
designed to minimize stagnation of circulating blood, sec-
ondary vortices developing deep in the pockets of the valve
leaflets can create potential stagnation zones. Such regions
of unsteady flow and low velocities could cause the acti-
vation of platelets that together with red blood cells can
form aggregates followed by infiltration of white blood cells
through the vessel wall and initiation of responses similar to
those observed in areas of trauma or atheroprone regions,
while NFAT in blood vascular endothelia is regulating the
activation of proinflammatory cells [74–76]. In addition, the
naturally hypoxic environment inside the veins can further
induce inflammatory responses in endothelial cells found in
stagnation zones, by inducing generation of reactive oxygen
species and NFjB [15, 17]. With ageing, a less thrombo-
resistant phenotype present in the venous valve and possible
alterations in the shear stress pattern or magnitude due to
inflammation can lead to valvular lesions that can have
important consequences on the normal function of the
vasculature [77]. In addition, age-related fibrosis and
thickening of venous valve leaflets and their decreased
compliance can disrupt normal blood flow and affect the
duration of blood stasis in the valve sinus, which can further
abrogate the development of thrombus [78, 79].
At the molecular level, little is known about the mech-
anisms regulating valve maintenance. Studies on genetic
mouse models have indicated important functions for both
Integrin-a9 and Ephrin-B2 in the maintenance of venous
valves, since conditional ablation of either gene in adult
mice led to regression of valve leaflets [32]. Ephrin-B2 is
additionally required for lymphatic valve maintenance
[32]. In addition, loss of Cnb1 in neonatal mice led to the
regression of lymphatic valve leaflets in mice, indicating a
continuous requirement for Calcineurin signaling for valve
maintenance [22].
Final remarks
The first observations on the development of lymphatic and
venous valves were made nearly 100 years ago [28, 29],
and today their importance for maintaining vascular func-
tion is well recognized, yet only recently have the
molecular mechanisms that regulate valve formation begun
to be elucidated. High-resolution imaging techniques and
genetic mouse models that allow targeting and visualiza-
tion of venous and lymphatic valves, as well as modeling
of human valve pathologies, will continue to increase our
understanding of the mechanisms that regulate valve
morphogenesis and contribute to diseases associated with
or caused by valvular dysplasia. Important questions of
clinical relevance that still remain to be investigated in
more detail are how valve development is initiated and
what are the mechanisms that regulate the maintenance and
normal function of valves during adulthood and aging.
Finally, identification of shared and distinct pathways that
regulate different types of valves should enable develop-
ment of diagnostic and therapeutic approaches for specific
targeting of venous and lymphatic valves.
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